Merck’s Keytruda fails as monotherapy in breast cancer study

55

Merck & Co Inc said on Monday its blockbuster cancer drug Keytruda failed to meet the main goal of a late-stage study testing the drug as a standalone treatment in patients with an aggressive type of breast cancer.

http://feeds.reuters.com/~r/reuters/healthNews/~3/CafMeUvJAgg/mercks-keytruda-fails-as-monotherapy-in-breast-cancer-study-idUSKCN1SQ299